First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry

Droz, Jean-Pierre; Efstathiou, Eleni; Yildirim, Asif; Cabrera, Paula; Kim, Choung; Horchani, Ali; Heidenreich, Axel; Rinck-Junior, Jose; Hitier, Simon; Ozen, Haluk

doi:10.1016/j.urolonc.2015.12.005

First-line treatment in senior adults with metastatic castration-resistant prostate cancer: A prospective international registry

Atıf İçin Kopyala

Droz J., Efstathiou E., Yildirim A., Cabrera P., Kim C. S., Horchani A., ...Daha Fazla

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, cilt.34, sa.5, 2016 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 34 Sayı: 5
Basım Tarihi: 2016
Doi Numarası: 10.1016/j.urolonc.2015.12.005
Dergi Adı: UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Hacettepe Üniversitesi Adresli: Evet

Özet

Aims: To compare the efficacy and tolerability of taxane and nontaxane therapy in senior adults with chemonaive metastatic castration resistant prostate cancer (mCRPC), and examine the effect of patient health status on outcomes.